Navigation Links
Angiotech's corporate partner, Cook Medical, announces positive interim results for its Zilver(R) PTX(TM) clinical study
Date:6/11/2008

Interim Results Show Promise for Improving the Treatment of Blockages in

the Femoropopliteal Artery

VANCOUVER, June 11 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, today announced that its corporate partner, Cook Medical, has reported positive interim results from the registry arm of a clinical study measuring the effectiveness of its Zilver PTX drug-eluting peripheral stent in treating peripheral arterial disease (PAD). The results, which were reported by the trial investigators last week at the 2008 SVS Vascular Annual Meeting, revealed clinical improvement, excellent durability and fracture resistance, and high rates of event-free survival (EFS) and freedom from target lesion revascularization (TLR). In addition, the Zilver stent exhibited no safety concerns and results were better than expected for TASC class C and D lesions, occlusions, in-stent restenosis and lesions greater than seven centimetres (2.75 inches).

"Building on the success of our paclitaxel-eluting coronary stents, we are extremely pleased that Cook has met with early success in leveraging our technology with this first round of positive trial data for the Zilver PTX paclitaxel-eluting peripheral stent," said Dr. William Hunter, President and CEO of Angiotech. "We are hopeful that Cook will encounter similarly positive results throughout the duration of the Zilver PTX trial and we are excited about the potential benefits the Zilver PTX stent may provide patients suffering from PAD."

Interim data was compiled at six and 12 months using 435 patients and 200 patients, respectively. The corresponding EFS rates were 94 percent and
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
2. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
3. Vical Names Andrew de Guttadauro Vice President, Corporate Development
4. Signalife Provides Corporate Update
5. Biomira Announces Plan to Reincorporate in the United States
6. Pressure BioSciences, Inc. Provides Corporate Update
7. The 4th Annual BIO Investor Forum to Webcast Alexzas Corporate Presentation
8. Clinsys Clinical Research, Inc. Announces Relocation of Corporate Headquarters
9. ProMed Alliance International Inc. Corporate Name and Trading Symbol Expected to Change Effective Tomorrow
10. MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated
11. New Corporate Website Launched - Focus on Life Scientists, Flow Cytometrists, & Clinicians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... even the entire body to visualize long-range connections between ... a long-time dream of biologists. A study published by ... Cell has now made that dream a ... and human tissue biopsies transparent, while keeping the cellular ... way for a better understanding of brain-body interactions, more ...
(Date:7/31/2014)... BLOOMINGTON, Ind. -- Chemists at Indiana University Bloomington ... in bricks-and-mortar fashion, a development with potential value ... as field-effect transistors and photovoltaic cells. , Their ... 3D Crystalline Solids and 2D Self-Assembled Crystals," has ... a journal of the Royal Society of Chemistry. ...
(Date:7/31/2014)... New York , July 31, 2014 ... by Transparency Market Research "Quantum Dots Market - Global ... - 2023," the market was valued at USD 88.5 ... 8,246.8 million by 2023, growing at a CAGR of ... full Quantum Dots Market Report at  http://www.transparencymarketresearch.com/quantum-dots.html ...
(Date:7/31/2014)... Graphite Metallizing Corporation announces GRAPHALLOY® bearings ... are uniquely suited to prevent loss of lubrication that ... high temperatures . , Recently, a manufacturer of ... at Graphite Metallizing to overcome problems with movement of ... pans containing blocks of powder mixture are loaded onto ...
Breaking Biology Technology:See-through organs and bodies will accelerate biomedical discoveries 2Chemists demonstrate 'bricks-and-mortar' assembly of new molecular structures 2Chemists demonstrate 'bricks-and-mortar' assembly of new molecular structures 3Global Quantum Dots Market is Expected to Reach USD 8,246.8 Million in 2023: Transparency Market Research 2Global Quantum Dots Market is Expected to Reach USD 8,246.8 Million in 2023: Transparency Market Research 3Global Quantum Dots Market is Expected to Reach USD 8,246.8 Million in 2023: Transparency Market Research 4Graphite Metallizing Announces Bearings for High Temperature Oven Applications 2Graphite Metallizing Announces Bearings for High Temperature Oven Applications 3
... SAN DIEGO, Oct. 27 BioAtom Inc. (private) announced,today ... Investor Conference on,Tuesday, October 28, 2008 at 2:30 PM ... in San Diego, California., Myron Karasik, M.B.A., C.M.C., ... of BioAtom Inc. of Costa Mesa, CA, dedicated,to development ...
... YORK, Oct. 24 The day of true ... study confirms the efficacy of a,revolutionary egg selection ... a viable and reliable fertility preservation option., ... ReproCure, a,vanguard genetics products company, this process increases ...
... /PRNewswire-FirstCall/ - AEterna Zentaris Inc.,(NASDAQ: AEZS ; ... therapy and oncology, today announced that it received ... Zentaris that during the 30,consecutive business days prior ... the,Company,s common shares had closed below the US$1.00 ...
Cached Biology Technology:BioAtom Inc. To Present at BIOCOM Investor Conference 2008 2Breakthrough Technology Takes Egg Freezing from Myth to Dependable Reality 2Breakthrough Technology Takes Egg Freezing from Myth to Dependable Reality 3Breakthrough Technology Takes Egg Freezing from Myth to Dependable Reality 4AEterna Zentaris Receives Notification from Nasdaq Relating to Minimum Bid Price 2AEterna Zentaris Receives Notification from Nasdaq Relating to Minimum Bid Price 3
(Date:7/31/2014)... An international team of scientists from Spain, France, ... rove beetle that is the oldest definitive member ... found in amber. The discovery and description were ... phase-contrast X-ray synchrotron imaging technique, which allows the ... amber. The new species is described in the ...
(Date:7/31/2014)... Edmond Becquerel first discovered the photovoltaic effect in 1839, ... power of sunlight for its own purposes. In a ... of the FASEB Journal , scientists ... power of sunlight by focusing on a naturally occurring ... evolution. This conservationor persistence over time and across speciessuggests ...
(Date:7/31/2014)... people are familiar with Hibiscus flowers- they are ... they are commonly planted in the landscape. Some, ... are endangered species. , Only a relatively few ... of an equally beautiful and intriguing related group ... "brother of Hibiscus". , Brother of Hibiscus species ...
Breaking Biology News(10 mins):Scientists shine bright new light on how living things capture energy from the sun 2Brother of Hibiscus is found alive and well on Maui 2
... researchers is examining a new vaccine method that may ... and his team of researchers is hoping to find ... smaller doses and require only one trip to the ... prepared from killed bacteria. The vaccinated person,s immune system ...
... of the future plan to confront the greatest scientific, ... inhabitants? This is the question being addressed at the ... Status and Perspective held by the Deutsche Forschungsgemeinschaft (DFG, ... Promotion of Science (JSPS), taking place in Hamburg this ...
... in French . A research ... Universitys Department of Microbiology and Immunology has discovered that ... the bodys autoimmune reactions may lose their effectiveness and ... type 1 diabetes. The study conducted on non-obese ...
Cached Biology News:Iowa State researchers look for smaller, cheaper, 1-dose vaccines 2Japanese and German researchers meet to discuss climate change 2Japanese and German researchers meet to discuss climate change 3Type 1 diabetes triggered by 'lazy' regulatory T-cells: McGill researchers 2